Form 4: MicroStrategy Director Stephen Graham Reports Stock Option Grant and RSU Vesting

Sentiment:

SEC Form 4 Filing


Stephen Graham, a director at MicroStrategy, reported the vesting of restricted stock units (RSUs) and the grant of stock options on May 31, 2024, according to a recent SEC Form 4 filing.

Summary

  • On May 31, 2024, MicroStrategy director Stephen Graham reported transactions involving the company's Class A Common Stock.
  • Graham had 497 restricted stock units vest.
  • He was also granted a stock option to purchase 139 shares of Class A Common Stock at a price of $1,524.49, expiring on May 31, 2034.
  • Additionally, he received 98 restricted stock units that will vest on the first anniversary of the grant date.
  • These grants were made under the MicroStrategy Incorporated 2023 Equity Incentive Plan, which provides for annual equity awards to non-employee directors.

Sentiment

Score: 7

Explanation: The document reflects standard director compensation practices, which is generally viewed neutrally to positively as it aligns director interests with shareholder value. There are no indications of unusual or concerning activity.

Positives

  • The equity incentive plan aligns the interests of non-employee directors with those of the shareholders.
  • The vesting of RSUs and granting of stock options are part of a pre-approved plan.

Future Outlook

The director will continue to vest in previously granted stock options and RSUs, and may receive additional grants in the future under the 2023 Equity Incentive Plan.

Industry Context

Director compensation through stock options and RSUs is a common practice in publicly traded companies to align the interests of directors with those of shareholders. The specific terms of the MicroStrategy plan appear to be fairly standard.

Comparison to Industry Standards

  • The MicroStrategy director compensation plan, providing $300,000 in annual equity awards, is within the typical range for companies of similar size and industry.
  • Companies like Palantir and Snowflake also utilize equity-based compensation for their directors.
  • The vesting schedules and exercise prices of the options are also consistent with standard practices.

Stakeholder Impact

  • The vesting of RSUs and granting of stock options could have a minor dilutive effect on existing shareholders.
  • The equity incentive plan is designed to motivate directors to act in the best interests of the company and its shareholders.

Key Dates

DateDescription
2018-05-311,250 shares of director stock option vested (exercise price $182.36, expiration May 31, 2027).
2019-05-311,250 shares of director stock option vested (exercise price $182.36, expiration May 31, 2027) and 1,250 shares of director stock option vested (exercise price $129.57, expiration May 31, 2028).
2020-05-311,250 shares of director stock option vested (exercise price $182.36, expiration May 31, 2027), 1,250 shares of director stock option vested (exercise price $129.57, expiration May 31, 2028) and 1,250 shares of director stock option vested (exercise price $132.91, expiration May 31, 2029).
2021-05-311,250 shares of director stock option vested (exercise price $182.36, expiration May 31, 2027), 1,250 shares of director stock option vested (exercise price $129.57, expiration May 31, 2028), 1,250 shares of director stock option vested (exercise price $132.91, expiration May 31, 2029) and 1,250 shares of director stock option vested (exercise price $124.48, expiration May 31, 2030).
2022-05-311,250 shares of director stock option vested (exercise price $129.57, expiration May 31, 2028), 1,250 shares of director stock option vested (exercise price $132.91, expiration May 31, 2029) and 1,250 shares of director stock option vested (exercise price $124.48, expiration May 31, 2030) and 1,250 shares of director stock option vested (exercise price $470.00, expiration May 31, 2031).
2023-05-311,250 shares of director stock option vested (exercise price $132.91, expiration May 31, 2029), 1,250 shares of director stock option vested (exercise price $124.48, expiration May 31, 2030), 1,250 shares of director stock option vested (exercise price $470.00, expiration May 31, 2031) and 1,250 shares of director stock option vested (exercise price $264.69, expiration May 31, 2032).
2024-05-31497 restricted stock units vested, stock option granted for 139 shares (exercise price $1,524.49, expiration May 31, 2034), 98 restricted stock units granted (vesting on the first anniversary), 1,250 shares of director stock option vested (exercise price $124.48, expiration May 31, 2030), 1,250 shares of director stock option vested (exercise price $470.00, expiration May 31, 2031), 1,250 shares of director stock option vested (exercise price $264.69, expiration May 31, 2032) and 761 shares of director stock option vested (exercise price $301.63, expiration May 31, 2033).
2024-06-04Date of signature for the SEC filing.
2025-05-311,250 shares of director stock option are scheduled to vest (exercise price $470.00, expiration May 31, 2031) and 1,250 shares of director stock option are scheduled to vest (exercise price $264.69, expiration May 31, 2032).
2026-05-311,250 shares of director stock option are scheduled to vest (exercise price $264.69, expiration May 31, 2032).
2027-05-31Expiration date for director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $182.36 per share.
2028-05-31Expiration date for director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $129.57 per share.
2029-05-31Expiration date for director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $132.91 per share.
2030-05-31Expiration date for director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $124.48 per share.
2031-05-31Expiration date for director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $470.00 per share.
2032-05-31Expiration date for director stock option to purchase 5,000 shares of Class A common stock with an exercise price of $264.69 per share.
2033-05-31Expiration date for director stock option to purchase 761 shares of Class A common stock with an exercise price of $301.63 per share.
2034-05-31Expiration date for the stock option granted on May 31, 2024, for 139 shares of Class A Common Stock at $1,524.49.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.